Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

Cohort A focused on patients with CLE or SLE with active lupus rash and evaluated organ-specific disease activity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity ...

Other candidates include anti-BDCA2 antibody litifilimab in phase 3 for SLE and phase 2 for cutaneous lupus erythematosus (CLE) – also partnered with UCB – and felzartamab, an anti-CD38 ...

DR-0201 is currently being evaluated in two phase 1 studies, one in the blood cancer non-Hodgkin lymphoma (NHL) and another in a range of autoimmune diseases including SLE, cutaneous lupus ...

Does Cutaneous Lupus Erythematosus Raise Risk for Atherosclerotic Cardiovascular Disease? news 2003 /viewarticle/1002109 ...

Clotting is a serious complication of systemic lupus erythematosus (SLE) for several reasons. First, clotting can cause persistent disability and death or fetal loss in pregnant women. Second, the ...

Surgery is the go-to treatment for cutaneous squamous cell carcinoma (CSCC) — a type of cancer that develops in the squamous cells of the skin. But there are other ways to treat the cancer if a ...

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for ...

In the successful cases, two patients with discoid lupus erythematosus used a formulation of 0.3% topical tacrolimus in 0.05% clobetasol propionate ointment twice daily, and favorable responses ...

Introduction. Systemic lupus erythematosus (SLE) is a B-lymphocyte-centered autoimmune disorder characterized by significant clinical heterogeneity and the involvement of multiple organ systems ...

Objective Early prediction of long-term outcomes in patients with systemic lupus erythematosus (SLE) remains a great challenge in clinical practice. Our study aims to develop and validate predictive ...